| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2016) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC27 |
| UNII: | TT6HN20MVF |
Pharmacology
| Primary Target | |
|---|---|
| platelet derived growth factor receptor alpha |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sarcoma | 4 | D012509 | ClinicalTrials |
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Sarcoma | 4 | D012509 | FDA |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Gastrointestinal Stromal Tumors | 2 | D046152 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Neoplasm Metastasis | 1 | D009362 | ClinicalTrials |
| Leiomyosarcoma | 1 | D007890 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1024603-93-7 |
| ChEMBL | CHEMBL1743049 |
| FDA SRS | TT6HN20MVF |
| Guide to Pharmacology | 9172 |
CONTENTS